{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.12.1031","meta":{"versionId":"20","lastUpdated":"2022-03-02T18:03:08.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031","version":"20170504","name":"Measles, Mumps and Rubella (MMR) Vaccine Administered","status":"active","date":"2022-03-03T18:46:01-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1085"]}]},"expansion":{"identifier":"urn:uuid:8face37c-5a0e-49ab-92cb-867080f5033b","timestamp":"2022-06-10T09:35:45-04:00","total":9,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"150971000119104","display":"Measles, mumps and rubella vaccination given (situation)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170433008","display":"Administration of second dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"38598009","display":"Administration of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"432636005","display":"Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"433733003","display":"Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"571591000119106","display":"Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"572511000119105","display":"Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90707","display":"Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90710","display":"Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use"}]}}